Newmark Group stock hits 52-week high at 17.45 USD

Published 15/08/2025, 19:00
Newmark Group stock hits 52-week high at 17.45 USD

Newmark Group Inc (NMRK) stock has reached a 52-week high, hitting a price of 17.45 USD. This milestone reflects a significant upward trend over the past year, with the stock delivering an impressive 39.12% return. According to InvestingPro analysis, the stock is currently trading near its Fair Value, with analysts setting price targets as high as $22.25. The commercial real estate advisory firm, now commanding a market capitalization of $4.21 billion, has seen its shares climb steadily, with a notable year-to-date return of 36.45%. This 52-week high underscores the company’s robust growth trajectory and its ability to capitalize on favorable market conditions. InvestingPro subscribers can access 15 additional investment tips and a comprehensive Pro Research Report for deeper insights into NMRK’s performance and outlook.

In other recent news, Newmark Group Inc. reported impressive second-quarter 2025 earnings, significantly surpassing analyst expectations. The company achieved an adjusted earnings per share of $0.31, outperforming the forecasted $0.252, and recorded a revenue of $759.1 million, which exceeded projections by 10.79%. This strong performance reflects a 23.02% earnings surprise and a broad-based revenue growth of approximately 20% year-over-year. JMP Securities responded to these results by reiterating its Market Outperform rating for Newmark Group and raising the stock price target from $17 to $19. The firm’s success was attributed to recent broker additions and a scalable platform that drove bottom-line outperformance.

Additionally, Newmark Group has expanded its presence in the western United States through a new alliance with Mountain West Commercial Real Estate. Under this agreement, Mountain West will operate as Newmark Mountain West, serving clients in Utah, Idaho, Wyoming, Montana, and Nevada. These developments underscore Newmark’s strategic growth initiatives and robust financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.